Challenges and Opportunities in Modernizing Clinical Trial Recruitment

&
Journal of Law, Medicine and Ethics 51 (2):314-321 (2023)
  Copy   BIBTEX

Abstract

Clinical trial recruitment is ripe for innovation. The current model is costly, often results in poor recruitment and offers inequitable access. To improve this system, we envision a peer-to-peer blockchain platform where patients control the depth and breadth of how their medical information is shared.

Categories

Keywords

Reprint years

DOI

10.1017/jme.2023.66

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,672

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Post-recruitment confirmation of informed consent by SMS.P. Gulbrandsen & B. F. Jensen - 2010 - Journal of Medical Ethics 36 (2):126-128.
Clinical Trial Informed Consent: Outsiders and the Love-Justice Correlation.John Robert Wilson - 1992 - Dissertation, Rice University
Interpreting clinical trial results by deductive reasoning: In search of improved trial design.Sven Kurbel & Slobodan Mihaljević - 2017 - Bioessays 39 (10):1700103.
At what degree of belief in a research hypothesis is a trial in humans justified?Benjamin Djulbegovic & Iztok Hozo - 2002 - Journal of Evaluation in Clinical Practice 8 (2):269-276.
Clinical trialist perspectives on the ethics of adaptive clinical trials: a mixed-methods analysis.Laurie J. Legocki, William J. Meurer, Shirley Frederiksen, Roger J. Lewis, Valerie L. Durkalski, Donald A. Berry, William G. Barsan & Michael D. Fetters - 2015 - BMC Medical Ethics 16 (1):27.
Remuneration in the United States and Mexico: Assessing the level of influence on potential clinical research participants about their decision to participate in a clinical trial and the risk of fraud.Jose Flores-Figueroa, Ingrid Badillo, Gilberto Botello, Ursus Pacheco, Mercedes Paredes-Paredes & Suzan McGovern - 2018 - Clinical Ethics 13 (2):98-105.
Toward a Jurisprudence of Drug Regulation.Matthew Herder - 2014 - Journal of Law, Medicine and Ethics 42 (2):244-262.
Redundant trials can be prevented, if the EU clinical trial regulation is applied duly.Daria Kim & Joerg Hasford - 2020 - BMC Medical Ethics 21 (1):1-19.
Characterizing the Population in Clinical Trials: Barriers, Comparability, and Implications for Review.Charles Weijer - unknown
Supporting positive experiences and sustained participation in clinical trials: looking beyond information provision.Kate Gillies & Vikki A. Entwistle - 2012 - Journal of Medical Ethics 38 (12):751-756.
Post-trial obligations.Doris Schroeder - unknown
Clinical Trial Application in Europe: What Will Change with the New Regulation?Viviana Giannuzzi, Annagrazia Altavilla, Lucia Ruggieri & Adriana Ceci - 2016 - Science and Engineering Ethics 22 (2):451-466.
Disclosing Clinical Trial Results: Publicity, Significance and Independence.S. Matthew Liao, Mark Sheehan & Steve Clarke - 2009 - American Journal of Bioethics 9 (8):3-5.
The Duty to Disclose Adverse Clinical Trial Results.S. Matthew Liao, Mark Sheehan & Steve Clarke - 2009 - American Journal of Bioethics 9 (8):24-32.
The evaluation of complex clinical trial protocols: resources available to research ethics committees and the use of clinical trial registries—a case study.Núria Homedes & Antonio Ugalde - 2015 - Journal of Medical Ethics 41 (6):464-469.

Analytics

Added to PP
2023-09-02

Downloads
5 (#1,535,575)

6 months
5 (#626,659)

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references